Innovative Health launches B2B platform for at-home testing
September 21, 2022 -- Innovative Health Diagnostics has launched a diagnostic-as-a-service (DaaS) platform that enables brands to offer at-home testing for initial diagnostics and recurring testing. Read More
Allelica launches polygenic risk score analysis as LDT
September 21, 2022 -- Allelica on Wednesday announced the launch of an ancestry-specific polygenic risk score (PRS) analysis as a laboratory-developed test (LDT) for coronary artery disease, breast cancer, prostate cancer, type 2 diabetes, and Alzheimer's disease. Read More
DxTerity receives NY authorization for SLE test
September 16, 2022 -- DxTerity Diagnostics on Friday announced that its Type-1 Interferon (IFN-1) test has received New York authorization, allowing it to be used in all 50 states. Read More
Aptorum provides update on its rapid MDx technology
September 15, 2022 -- Oncology, autoimmune disease, and infectious disease firm Aptorum on Thursday announced an update of the analytical, retrospective, and prospective clinical validation of its rapid pathogen identification and detection molecular diagnostics (Rpidd) technology. Read More
Prometheus, Takeda launch prognostic tool for Crohn’s
September 15, 2022 -- Prometheus Laboratories on Wednesday announced a partnership with Takeda Pharmaceutical to launch CDPath, a prognostic tool to monitor patients with Crohn’s disease (CD). Read More
Qiagen, Neuron23 to develop CDx for Parkinson’s
September 14, 2022 -- Qiagen and Neuron23 on Wednesday announced they have signed an agreement to develop a companion diagnostic (CDx) for Neuron23’s brain penetrant leucine-rich repeat kinase (LRRK2) inhibitor for Parkinson’s disease. Read More
Foundation Medicine, Relay Therapeutics to collaborate
September 12, 2022 -- Foundation Medicine and Relay Therapeutics said Monday that they plan to collaborate on developing the FoundationOne CDx as a companion diagnostic tool for use with Relay's FGFR2 inhibitor, RLY-4008l. Read More
Diadem nabs $2.5M to further validate Alzheimer’s blood test
September 7, 2022 -- Diadem U.S. announced on Wednesday that the National Institutes of Health’s National Institute on Aging (NIA) had awarded it approximately $2.5 million as part of a Small Business Innovation Research (SBIR) direct to Phase II grant. Read More
QuantuMDx, Sansure ink agreement for MDx POC system, tests
September 6, 2022 -- QuantuMDx said Tuesday that it has entered a cooperation agreement with Sansure Biotech to accelerate the commercialization of the QuantuMDx Q-POC multiplex PCR platform and its assays in China. Read More
AACC on POC tests for fertility, reproductive health
September 1, 2022 -- AACC on Thursday announced it has issued new guidance with expert recommendations for performing point-of-care tests for fertility and reproductive health. Read More